FSD Pharma

FSD Pharma

Verified
FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.

Launch date
Employees
Market cap
$7.1m
Net debt
$1.5m
Enterprise valuation
$6m (Public information from Jun 2024)
Cobourg Ontario (HQ & founding location)
Deals in current and previous year:

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2019202020212022202320242025
Revenues0000000000000000000000000000
% growth601 %-----206 %
EBITDA0000000000000000000000000000
% EBITDA margin(12872 %)------
Profit0000000000000000000000000000
% profit margin(20231 %)------
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

$0.0

round
N/A

$0.0

round
N/A

$0.0

round
N/A

$0.0

round
N/A

$0.0

round
N/A

$0.0

round
*
N/A

$11.2m

Post IPO Equity
Total Funding000k

Recent News about FSD Pharma

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by FSD Pharma

Edit
Prismic Pharmaceuticals
ACQUISITION by FSD Pharma Apr 2019
Therapix Biosciences
ACQUISITION by FSD Pharma Oct 2018
Lucid Psycheceuticals
ACQUISITION by FSD Pharma Aug 2021